NewEdge Advisors’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695 Hold
31
﹤0.01% 4028
2026
Q1
$848 Hold
31
﹤0.01% 3926
2025
Q4
$1.29K Hold
31
﹤0.01% 3955
2025
Q3
$1.43K Sell
31
-5
-14% -$267 ﹤0.01% 3837
2025
Q2
$1.91K Sell
36
-65
-64% -$3.43K ﹤0.01% 3628
2025
Q1
$5.63K Hold
101
﹤0.01% 3270
2024
Q4
$4.38K Buy
101
+47
+87% +$2.09K ﹤0.01% 3273
2024
Q3
$2.77K Hold
54
﹤0.01% 3320
2024
Q2
$3.42K Sell
54
-67
-55% -$4.02K ﹤0.01% 3200
2024
Q1
$8.02K Buy
121
+42
+53% +$3.41K ﹤0.01% 2969
2023
Q4
$7.76K Buy
79
+30
+61% +$2.61K ﹤0.01% 2959
2023
Q3
$3.92K Sell
49
-15
-23% -$1.18K ﹤0.01% 2879
2023
Q2
$5.17K Hold
64
﹤0.01% 2803
2023
Q1
$7.78K Sell
64
-300
-82% -$40.7K ﹤0.01% 2647
2022
Q4
$40K Buy
+364
New +$44.2K ﹤0.01% 1812

Other funds holding CNXC

NewEdge Advisors's CNXC Position: Q2 2026 in Review

NewEdge Advisors held its Concentrix (CNXC) position steady in Q2 2026 at 31 shares worth $695. The position accounts for ﹤0.01% of the portfolio, ranked #4028.

NewEdge Advisors first reported a position in CNXC in Q4 2022 and has held it in 15 quarters since. The position peaked at $40K in Q4 2022. 200 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • NewEdge Advisors held 31 shares of Concentrix worth $695 as of Q2 2026.
  • NewEdge Advisors left its Concentrix share count unchanged in Q2 2026.
  • Concentrix made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4028 holding.
  • NewEdge Advisors first reported a position in Concentrix in Q4 2022 and has held it in 15 quarters since.
  • NewEdge Advisors's Concentrix position peaked at $40K in Q4 2022.
  • 200 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.